Strategic and financial advisory as well as seed financing for early stage ventures.

Focus on RNA-based genomic and precision medicine, individualized therapeutics, in vivo gene therapy & editing, and AI guided synthetic biology.

Venture Seed Capital

First institutional capital and a route to the investors syndicate that will fund a biotech venture from concept to clinical readiness.

• Direct pre-seed and seed investments
• Access to angel investors and institutional venture capital networks
• Investor memorandums and pitch deck preparation
• Structuring equity and debt financing rounds

Strategic & Business Planning

Turning scientific innovation into a defensible commercial plan that investors and partners can underwrite.

• Translating complex science into business opportunities and investable theses
• Competitive landscape analysis and intellectual property assessment
• Help leadership team navigate inflection points where scientific milestones meet capital markets decisions
• Financial modeling and company valuations

Business & Corporate Development

Sourcing, structuring and closing the partnerships that define a biotech company’s trajectory.

• Structuring and negotiating academic technology in-licensing
• Identifying pharma and biotech R&D collaboration partners
• Structuring and negotiating in and out-licensing and joint development agreements 
• Run disciplined strategic partnerships and M&A advisory processes